Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX – Get Free Report) crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.27 and traded as high as $0.3750. Eagle Pharmaceuticals shares last traded at $0.3750, with a volume of 2,190 shares trading hands.
Eagle Pharmaceuticals Price Performance
The firm has a market capitalization of $4.87 million, a PE ratio of 0.32 and a beta of 0.83. The firm has a fifty day moving average price of $0.27 and a 200 day moving average price of $0.46.
About Eagle Pharmaceuticals
Eagle Pharmaceuticals, Inc is a specialty pharmaceutical company headquartered in Woodcliff Lake, New Jersey, that focuses on the development, manufacturing and commercialization of hospital-administered therapies in the areas of critical care, oncology and rare diseases. Founded in 2007, Eagle has built expertise in complex injectable formulations and orphan drug designation, aiming to address unmet medical needs through both novel products and reformulated generics.
The company’s marketed portfolio in the United States includes Bendeka®, an intravenous formulation of bendamustine for certain types of leukemia and lymphoma; Beleodaq®, approved for relapsed or refractory peripheral T-cell lymphoma; and Empaveli®, a complement inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria.
Read More
- Five stocks we like better than Eagle Pharmaceuticals
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for Eagle Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eagle Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
